Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/35885
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorGranados Vega, Elkyn Johan-
dc.contributor.authorCeballos Rueda, Javier Mauricio-
dc.contributor.authorAmariles Muñóz, Pedro-
dc.date.accessioned2023-07-12T15:35:50Z-
dc.date.available2023-07-12T15:35:50Z-
dc.date.issued2018-
dc.identifier.citationGranados, Johan, Ceballos, Mauricio, & Amariles, Pedro. (2018). Disglucemia asociada a fluoroquinolonas: una revisión estructurada. Revista médica de Chile, 146(5), 618-626. https://dx.doi.org/10.4067/s0034-98872018000500618spa
dc.identifier.issn0034-9887-
dc.identifier.urihttps://hdl.handle.net/10495/35885-
dc.description.abstractABSTRACT: Fluoroquinolone type antimicrobials can cause hypo or hyperglycemia in certain patients. We performed a structured review about this side effect, searching articles published in English or Spanish with full text access in PubMed/Medline. The following MESH terms were used: Hypoglycemia, Hyperglycemia, Quinolones, Ciprofloxacin, Levofloxacin, Moxifloxacin. Additionally, we evaluated the clinical relevance of potential drug interactions, based on the probability of occurrence and the severity of the interaction effect. We obtained 42 publications about the issue; 22 references were selected, where the severity of the interaction in patients with risk factors was evaluated. Patients receiving antidiabetic medications and with risk factors such as advanced age and renal failure may be more likely to have a severe hypoglycemia. In these patients, this drug interaction should be considered clinically relevant since its risk is high or very high.spa
dc.format.extent9spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherSociedad Médica de Santiagospa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by/2.5/co/*
dc.titleDisglucemia asociada a fluoroquinolonas: una revisión estructuradaspa
dc.title.alternativeHypo or hyperglycemia associated with fluoroquinolone usespa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Investigación de Tecnología en Regencia de Farmaciaspa
dc.publisher.groupPromoción y Prevención Farmacéuticaspa
dc.identifier.doi10.4067/s0034-98872018000500618-
oaire.versioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn0717-6163-
oaire.citationtitleRevista Médica de Chilespa
oaire.citationstartpage618spa
oaire.citationendpage626spa
oaire.citationvolume146spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by/4.0/spa
dc.publisher.placeSantiago, Chilespa
dc.type.coarhttp://purl.org/coar/resource_type/c_dcae04bcspa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTREVspa
dc.type.localArtículo de revisiónspa
dc.subject.decsDiabetes Mellitus-
dc.subject.decsFluoroquinolonas - efectos adversos-
dc.subject.decsFluoroquinolones - adverse effects-
dc.subject.decsHiperglucemia - inducido químicamente-
dc.subject.decsHyperglycemia - chemically induced-
dc.subject.decsHipoglucemia - inducido químicamente-
dc.subject.decsHypoglycemia - chemically induced-
dc.subject.decsÍndice de Severidad de la Enfermedad-
dc.subject.decsSeverity of Illness Index-
dc.subject.decsQuinolonas-
dc.subject.agrovocQuinolones-
dc.description.researchgroupidCOL0135121spa
dc.description.researchgroupidCOL0074661spa
dc.relation.ispartofjournalabbrevRev. Med. Chil.spa
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
CeballosMauricio_2018_DisglucemiaAsociadaFluoroquinolas.pdfArtículo de Revisión1.02 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons